Indapamide Dosage Recommendations
For hypertension, start indapamide at 1.25 mg once daily in the morning, increasing to 2.5 mg daily after 4 weeks if needed; for edema from heart failure, start at 2.5 mg once daily. 1
Hypertension Dosing
The FDA-approved dosing for hypertension follows a stepwise approach 1:
- Initial dose: 1.25 mg once daily (morning)
- After 4 weeks: If inadequate response, increase to 2.5 mg once daily
- After another 4 weeks: If still inadequate, may increase to 5 mg once daily, though adding another antihypertensive agent should be strongly considered at this point
The 2025 AHA/ACC guidelines specifically recommend indapamide 1.25-2.5 mg daily as a preferred thiazide-like diuretic for resistant hypertension, particularly when replacing standard thiazide diuretics like hydrochlorothiazide 2. This recommendation reflects indapamide's superior efficacy profile compared to traditional thiazides.
Important Dosing Considerations
Doses above 2.5 mg provide minimal additional blood pressure reduction but significantly increase the risk of hypokalemia 1. Clinical trials demonstrate that 5 mg and 10 mg doses are not distinguishable from each other in antihypertensive effect, though they cause progressively more potassium loss (0.5 mEq/L at 2.5 mg vs 0.6 mEq/L at 5 mg) 1.
Edema from Congestive Heart Failure
For edema management 1:
- Initial dose: 2.5 mg once daily (morning)
- After 1 week: If inadequate response, increase to 5 mg once daily
Combination Therapy
When combining indapamide with other antihypertensives, reduce the usual dose of the other agent by 50% initially, then titrate based on blood pressure response 1. The 2025 guidelines emphasize using indapamide as part of a preferred triple combination with ACE inhibitor/ARB plus calcium channel blocker for resistant hypertension 2.
Severe Renal Impairment
Indapamide can be safely used in patients with renal impairment without dose adjustment 1, 3. This is a critical advantage over other diuretics. Key evidence:
- The drug does not accumulate in patients with chronic kidney disease 3
- It remains effective across varying degrees of renal function 1, 4
- It is not dialyzable, making it suitable for hemodialysis patients 3
- For CKD stage 4 or greater, the 2025 guidelines recommend chlorthalidone or loop diuretics over thiazide-like diuretics in general 2, though indapamide's unique pharmacokinetics may still allow use
Common pitfall: Unlike hydrochlorothiazide, which loses efficacy as GFR declines, indapamide maintains antihypertensive effects even with significant renal impairment due to its dual mechanism (diuretic plus direct vasodilator effects) 5, 4.
Pediatric Dosing
Indapamide is not FDA-approved for pediatric use 6, 1. The 2011 pediatric hypertension guidelines do not include indapamide in their recommended agents, listing only hydrochlorothiazide, chlorthalidone, furosemide, and potassium-sparing diuretics for children 6. There is minimal clinical trial experience in pediatric populations.
Practical Considerations
- Timing: Always administer in the morning to avoid nocturia 1
- Food: Can be taken with or without food; bioavailability is unaffected 5
- Duration of action: 24-hour coverage with once-daily dosing 1
- Monitoring: Check electrolytes shortly after initiation and periodically thereafter, particularly potassium levels 1